Carboplatin-Paclitaxel-Rucaparib-Bevacizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Carboplatin-Paclitaxel-Rucaparib-Bevacizumab, covering 2021-08-27 to 2021-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination [Phase 1, Phase 2]